BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7817798)

  • 1. Interleukin-4 inhibits spontaneous and parathyroid hormone-related protein-stimulated osteoclast formation in mice.
    Nakano Y; Watanabe K; Morimoto I; Okada Y; Ura K; Sato K; Kasono K; Nakamura T; Eto S
    J Bone Miner Res; 1994 Oct; 9(10):1533-9. PubMed ID: 7817798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.
    Uy HL; Mundy GR; Boyce BF; Story BM; Dunstan CR; Yin JJ; Roodman GD; Guise TA
    Cancer Res; 1997 Aug; 57(15):3194-9. PubMed ID: 9242449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of infusion of human parathyroid hormone-related protein-(1-40) in nude mice: histomorphometric and biochemical investigations.
    Rosol TJ; Capen CC; Horst RL
    J Bone Miner Res; 1988 Dec; 3(6):699-706. PubMed ID: 2855193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged decrease of serum calcium concentration by murine gamma-interferon in hypercalcemic, human tumor (EC-GI)-bearing nude mice.
    Sato K; Satoh T; Shizume K; Yamakawa Y; Ono Y; Demura H; Akatsu T; Takahashi N; Suda T
    Cancer Res; 1992 Jan; 52(2):444-9. PubMed ID: 1728416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Passive immunization with anti-parathyroid hormone-related protein monoclonal antibody markedly prolongs survival time of hypercalcemic nude mice bearing transplanted human PTHrP-producing tumors.
    Sato K; Yamakawa Y; Shizume K; Satoh T; Nohtomi K; Demura H; Akatsu T; Nagata N; Kasahara T; Ohkawa H
    J Bone Miner Res; 1993 Jul; 8(7):849-60. PubMed ID: 8352067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
    Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of interleukin-6 in uncoupling of bone in vivo in a human squamous carcinoma coproducing parathyroid hormone-related peptide and interleukin-6.
    Nagai Y; Yamato H; Akaogi K; Hirose K; Ueyama Y; Ikeda K; Matsumoto T; Fujita T; Ogata E
    J Bone Miner Res; 1998 Apr; 13(4):664-72. PubMed ID: 9556066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1 receptor antagonist inhibits the hypercalcemia mediated by interleukin-1.
    Guise TA; Garrett IR; Bonewald LF; Mundy GR
    J Bone Miner Res; 1993 May; 8(5):583-7. PubMed ID: 8511985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy.
    Oyajobi BO; Anderson DM; Traianedes K; Williams PJ; Yoneda T; Mundy GR
    Cancer Res; 2001 Mar; 61(6):2572-8. PubMed ID: 11289133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suramin suppresses hypercalcemia and osteoclastic bone resorption in nude mice bearing a human squamous cancer.
    Yoneda T; Williams P; Rhine C; Boyce BF; Dunstan C; Mundy GR
    Cancer Res; 1995 May; 55(9):1989-93. PubMed ID: 7728770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid hormone-related protein and interleukin-1 alpha synergistically stimulate bone resorption in vitro and increase the serum calcium concentration in mice in vivo.
    Sato K; Fujii Y; Kasono K; Ozawa M; Imamura H; Kanaji Y; Kurosawa H; Tsushima T; Shizume K
    Endocrinology; 1989 May; 124(5):2172-8. PubMed ID: 2539970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of humoral hypercalcemia of malignancy in rats with inhibitors of carbonic anhydrase.
    Brown GM; Morris CA; Mitnick MA; Insogna KL
    J Bone Miner Res; 1990 Oct; 5(10):1037-41. PubMed ID: 1964358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of dual signal transduction systems in the stimulation of osteoclast-like cell formation by parathyroid hormone and parathyroid hormone-related peptide.
    Kaji H; Sugimoto T; Kanatani M; Fukase M; Chihara K
    Biochem Biophys Res Commun; 1993 Jul; 194(1):157-62. PubMed ID: 8392835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnesium deficiency: effect on bone and mineral metabolism in the mouse.
    Rude RK; Gruber HE; Wei LY; Frausto A; Mills BG
    Calcif Tissue Int; 2003 Jan; 72(1):32-41. PubMed ID: 12370796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of parathyroid hormone (PTH)-related protein and PTH on osteoclasts and osteoclast precursors in vivo.
    Uy HL; Guise TA; De La Mata J; Taylor SD; Story BM; Dallas MR; Boyce BF; Mundy GR; Roodman GD
    Endocrinology; 1995 Aug; 136(8):3207-12. PubMed ID: 7628353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoprotegerin prevents and reverses hypercalcemia in a murine model of humoral hypercalcemia of malignancy.
    Capparelli C; Kostenuik PJ; Morony S; Starnes C; Weimann B; Van G; Scully S; Qi M; Lacey DL; Dunstan CR
    Cancer Res; 2000 Feb; 60(4):783-7. PubMed ID: 10706080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of low calcium diet, mithramycin, and dichlorodimethylene bisphosphonate on humoral hypercalcemia of malignancy in nude mice transplanted with the canine adenocarcinoma tumor line (CAC-8).
    Rosol TJ; Capen CC
    J Bone Miner Res; 1987 Oct; 2(5):395-405. PubMed ID: 2971305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo evidence for progressive activation of parathyroid hormone-related peptide gene transcription with tumor growth and stimulation of osteoblastic bone formation at an early stage of humoral hypercalcemia of cancer.
    Yamato H; Nagai Y; Inoue D; Ohnishi Y; Ueyama Y; Ohno H; Matsumoto T; Ogata E; Ikeda K
    J Bone Miner Res; 1995 Jan; 10(1):36-44. PubMed ID: 7747629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human cystatin C, a cysteine proteinase inhibitor, inhibits bone resorption in vitro stimulated by parathyroid hormone and parathyroid hormone-related peptide of malignancy.
    Lerner UH; Grubb A
    J Bone Miner Res; 1992 Apr; 7(4):433-40. PubMed ID: 1319105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combined effect of tumor-produced parathyroid hormone-related protein and transforming growth factor-alpha enhance hypercalcemia in vivo and bone resorption in vitro.
    Guise TA; Yoneda T; Yates AJ; Mundy GR
    J Clin Endocrinol Metab; 1993 Jul; 77(1):40-5. PubMed ID: 8325957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.